References
Rochling FA, Zetterman RK. Management of ascites. Drugs 2009; 69(13): 1739–60
Runyon BA. Management of adult patients with ascites due to cirrhosis. Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Hepatology 2004 Mar; 39(3): 841–56
Garcia-Tsao G, Lim JK, Members of Veterans Affairs Hepatitis C Resource Center Program. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol 2009 Jul; 104(7): 1802–29
Sanyal AJ, Bosch J, Blei A, et al. Portal hypertension and its complications. Gastroenterology 2008 May; 134(6): 1715–28
Garcia-Pagan JC, Groszmann R, Bosch J. Portal hypertension. In: Weinstein WM, Hawkey CJ, Bosch J, editors. Portal hypertension, 1st ed. Philadelphia (PA): Elsevier Mosby, 2005: 707–16
Ginés P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987 Jan–Feb; 7(1): 122–8
Planas R, Montoliu S, Ballesté B, et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol 2006 Nov; 4(11): 1385–94
D’Amico G, Morabito A, Pagliaro L, et al. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986 May; 31(5): 468–75
Dib N, Oberti F, Calès P. Current management of the complications of portal hypertension: variceal bleeding and ascites. CMAJ 2006 May 9; 174(10): 1433–43
Cárdenas A, Ginés P. Portal hypertension. Curr Opin Gastroenterol 2009 May; 25(3): 195–201
Rights and permissions
About this article
Cite this article
Implement additional treatments as ascites caused by portal hypertension progresses. Drugs Ther. Perspect 26, 16–18 (2010). https://doi.org/10.2165/11205360-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11205360-000000000-00000